Jeremy John Edmunds

Title: Innovations by Jeremy John Edmunds in Thrombotic Disorder Treatments

Introduction

Jeremy John Edmunds, hailing from Ypsilanti, MI, is a notable inventor with a remarkable portfolio consisting of 19 patents. His work primarily focuses on developing innovative solutions in the field of medicinal chemistry, specifically targeting thrombotic disorders.

Latest Patents

Among his notable inventions are the inhibitors of factor Xa and other serine proteases involved in the coagulation cascade. The patent provides compounds of Formula (I), which are useful for treating thrombotic disorders. These compounds and their pharmaceutically acceptable salts are fundamental in creating effective pharmaceutical compositions. The documentation also outlines processes for preparing these compounds and the intermediates used in their synthesis.

Career Highlights

Throughout his career, Jeremy has been associated with prominent companies, including Warner-Lambert Company and Pfizer Corporation. His experiences in these organizations have significantly contributed to his expertise and innovative capabilities in the pharmaceutical industry.

Collaborations

Jeremy has worked alongside skilled professionals such as Kent A. Berryman and Annette M. Doherty. These collaborations have been vital in advancing his research and patent developments, allowing for a more extensive exploration of innovative treatments.

Conclusion

Jeremy John Edmunds is a distinguished inventor whose contributions to the field of thrombotic disorder treatments are significant. With a robust portfolio of patents and invaluable collaborations, he continues to influence the landscape of medicinal chemistry with his innovative solutions.